| Integrative genomic analysis reveals cancer-associated mutations at diagnosis of CML in patients with high-risk disease S Branford, P Wang, DT Yeung, D Thomson, A Purins, C Wadham, ... Blood, The Journal of the American Society of Hematology 132 (9), 948-961, 2018 | 182 | 2018 |
| Unbiased cell surface proteomics identifies SEMA4A as an effective immunotherapy target for myeloma GSF Anderson, J Ballester-Beltran, G Giotopoulos, JA Guerrero, S Surget, ... Blood, The Journal of the American Society of Hematology 139 (16), 2471-2482, 2022 | 14 | 2022 |
| Is the revised International staging system for myeloma valid in a real world population? I Walker, A Coady, M Neat, D Ladon, R Benjamin, I El‐Najjar, M Kazmi, ... British Journal of Haematology 180 (3), 2018 | 14 | 2018 |
| SGK1 mutations in DLBCL generate hyperstable protein neoisoforms that promote AKT independence J Gao, E Sidiropoulou, I Walker, JA Krupka, K Mizielinski, Z Usheva, ... Blood, The Journal of the American Society of Hematology 138 (11), 959-964, 2021 | 11 | 2021 |
| Thrombus distribution in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination P Rogers, I Walker, J Yeung, A Khan, A Gangi, B Mobashwera, R Ayto, ... Radiology 305 (3), 590-596, 2022 | 6 | 2022 |
| Acquired CARD11 mutation promotes BCR independence in diffuse large B cell lymphoma R Caeser, I Walker, J Gao, N Shah, L Rasso-Barnett, S Anand, JE Martin, ... JCO precision oncology 5, 2021 | 5 | 2021 |
| High incidence of mutated cancer-associated genes at diagnosis in CML patients with early transformation to blast crisis S Branford, PPS Wang, WT Parker, D Yeung, JE Marum, D Stangl, ... Blood 126 (23), 600, 2015 | 5 | 2015 |
| Allogeneic anti-Bcma CAR-T cells show tumour specific killing against primary multiple myeloma cells from different genomic sub-groups AM Metelo, I Walker, A Jozwik, C Graham, C Attwood, K Sanchez, ... Blood 134, 1834, 2019 | 4 | 2019 |
| Novel fusion genes at CML diagnosis reveal a complex pattern of genomic rearrangements and sequence inversions associated with the Philadelphia chromosome in patients with … JE Marum, PPS Wang, D Stangl, DT Yeung, MC Mueller, CT Dietz, ... Blood 128 (22), 1219, 2016 | 3 | 2016 |
| Red cell haemolysis secondary to intraosseous (IO) blood transfusion in adult patients with major trauma: a systematic review M Ellington, I Walker, E Barnard BMJ Mil Health, 2023 | 2 | 2023 |
| A case of thrombotic microangiopathy and acute sarcoidosis AW Martinelli, W Dunn, ME McClure, I Walker, A Stewart, S Karia, ... Chest 162 (5), e245-e248, 2022 | 2 | 2022 |
| OAB-018: From CARDAMON to CoMMpass: a mutational signature that predicts carfilzomib-specific outcomes in myeloma I Walker, G Khandelwal, V D’Arcy, W Wilson, E Fitzsimons, ... Clinical Lymphoma Myeloma and Leukemia 22, S11-S12, 2022 | 1 | 2022 |
| A single centre retrospective analysis of diagnostic fluorescence in situ hybridisation reveals distinct groups of cytogenetic abnormalities, which affect early survival of new … I Walker, G Double, G Milner, M Kazmi, E Najjar, M Neat, S Schey, ... Clinical Lymphoma, Myeloma and Leukemia 15, e116, 2015 | 1 | 2015 |
| Targeting myeloma essential genes using NOT Gated CAR T-cells, a computational approach IG Walker, JP Roy, GSF Anderson, J Guerrero Lopez, MA Chapman Leukemia, 1-5, 2024 | | 2024 |
| Targeting myeloma essential genes using NOT Gated CAR T-cells, a computational approach M Chapman, I Walker Springer Nature [academic journals on nature. com], 2024 | | 2024 |
| High Neoantigen Load Confers a Major Benefit from Autologous Stem Cell Transplantation Compared to Consolidation in Newly Diagnosed Multiple Myeloma I Walker, V D'Arcy, K Foster, G Khandelwal, GSF Anderson, W Wilson, ... Blood 142, 3306, 2023 | | 2023 |
| And-Gate CAR T-Cells to Improve Tumour Specificity and Targeting of Low-Expression Antigens in Multiple Myeloma GSF Anderson, I Walker, JP Roy, MA Chapman Blood 142, 751, 2023 | | 2023 |
| Machine learning from the CARDAMON trial identifies a carfilzomib-specific mutational response signature IG Walker, V D’arcy, G Khandelwal, G Anderson, A Aubareda, W Wilson, ... medRxiv, 2023.04. 08.23288287, 2023 | | 2023 |
| Cell surface proteomics reveal a strategy for targeting myeloma through combinatorial targeting of TNFRSF8 and TMPRSS11E GSF Anderson, IG Walker, JP Roy, MA Chapman bioRxiv, 2023.04. 04.535580, 2023 | | 2023 |
| A machine learning approach to predict drug-induced autoimmunity using transcriptional data. GL Smith, IG Walker, A Aubareda, MA Chapman bioRxiv, 2023.04. 04.533417, 2023 | | 2023 |
